| CRISPR Medicine | This is an overview of our news stories
A new computational framework called CCLMoff uses deep learning and RNA language models to predict off-target effects in CRISPR-CAS9 genome editing...
Modalis Therapeutics has partnered with SOLVE FSHD to advance the development of an experimental epigenome-editing therapy for facioscapulohumeral...
Some of the best links we picked up around the internet
Using CRISPR-Cas9 screens, researchers in the United States, Belgium and China have identified NR2F2 as a key driver of endocrine resistance in breast...
New clinical data from Allogene Therapeutics' Phase 1 TRAVERSE trial reveals durable responses in patients with heavily pre-treated advanced renal...
Today, researchers in researchers in South Korea announced a method to selectively install N4-acetylcytidine (ac4C) modifications on specific RNA...
Researchers in Spain and Germany report using CRISPR-mediated exon removal to restore collagen production in cells from patients with recessive...
